These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3136464)

  • 1. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
    Loosen PT; Marciniak R
    Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine abnormalities in affective disorders.
    Extein I; Pottash AL; Gold MS
    Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
    Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological markers of melancholia and reclassification of depressive disorders.
    Greden JF
    Encephale; 1982; 8(2):193-202. PubMed ID: 6809444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
    Chen G
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):203-6, 251. PubMed ID: 1954790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
    Rush AJ; Schlesser MA; Roffwarg HP; Giles DE; Orsulak PJ; Fairchild C
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):23-9. PubMed ID: 6409892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary sensitivity to thyroid hormones in depressed patients.
    Loosen PT; Garbutt JC; Dew B; Prange AJ
    Pharmacopsychiatry; 1987 May; 20(3):85-9. PubMed ID: 3110799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
    Schatzberg AF; Orsulak PJ; Rothschild AJ; Salomon MS; Lerbinger J; Kizuka PP; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD
    Biol Psychiatry; 1984 Mar; 19(3):305-18. PubMed ID: 6426529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics.
    Dackis CA; Pottash AL; Bailey J; Stuckey RF; Extein IL; Gold MS
    NIDA Res Monogr; 1983 Apr; 43():266-72. PubMed ID: 6410260
    [No Abstract]   [Full Text] [Related]  

  • 14. [Usefulness of neuroendocrine function tests in the differential diagnosis of depression].
    Cervera S
    Rev Esp Fisiol; 1989; 45 Suppl():279-87. PubMed ID: 2518335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Platelet monoamine oxidase and sex hormones in a population of depressed patients].
    Poirier MF; Lôo H; Lefur G; Mitrani N
    Encephale; 1985; 11(3):125-9. PubMed ID: 4029076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DST urinary MHPG.SO4 excretion and platelet MAO activity in depression].
    Zhou DF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):274-8. PubMed ID: 3833511
    [No Abstract]   [Full Text] [Related]  

  • 17. Sub-biochemical hypothyroidism: an exaggerated thyroid stimulating hormone response to thyrotrophin releasing hormone.
    Sheth JJ; Thakore PB; Trivedi BB; Shah NN; Vaidya RA
    J Assoc Physicians India; 1999 Mar; 47(3):275-9. PubMed ID: 10999119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
    Schatzberg AF; Rothschild AJ; Gerson B; Lerbinger JE; Schildkraut JJ
    Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet MAO activity and the cortisol response to dexamethasone in major depression.
    Meltzer HY; Lowy MT; Locascio JJ
    Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression.
    Bloomingdale KL; Vasile RG; Gudeman JE; Gerson B; Schildkraut JJ
    Biol Psychiatry; 1986 Apr; 21(4):390-3. PubMed ID: 3955113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.